Click here to view images in this message
North Bay Business Journal

November 26th, 2014

Breaking News

BioMarin offers $840M for muscular dystrophy drug-maker

San Rafael-based BioMarin Pharmaceutical on Monday said it will offer to buy Prosensa Holding N.V., parent of The Netherlands-based Prosensa Therapeutics, for its drisapersen drug used to treat Duchenne muscular dystrophy in a deal that could total $840 million.